SCHEMBL30058680

SCHEMBL30058680

CCCCOC(=O)C1(c2cc(Br)ccn2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 3/20 0.40
▸ ATM Q13315 1/20 0.40
▸ LMNA P02545 3/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ MAPT P10636 1/20 0.37
▸ THRA P10827 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ TSHR P16473 2/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ PDE4D Q08499 1/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ GAA P10253 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9988666 0.87 OPRM1 (0.41) —
SCHEMBL23365196 0.82 OPRM1 (0.39) MEN1KMT2ASMN1; SMN2
SCHEMBL28398405 0.80 ALDH1A1 (0.40) MEN1KMT2AMAPTALDH1A1TSHR
SCHEMBL23730076 0.78 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2GAAKDM4EMAPK1
SCHEMBL22290800 0.76 DGAT1 (0.38) ALDH1A1PDE4DSMN1; SMN2KDM4E
SCHEMBL348542 0.76 ALDH1A1 (0.49) LMNAMEN1KMT2ATHRBALDH1A1
SCHEMBL23365085 0.73 KDM4E (0.49) MAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL5700005 0.73 SMN1; SMN2 (0.50) ESR1ATMLMNAMEN1KMT2A
SCHEMBL29284164 0.72 KDM4E (0.43) LMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL29284906 0.72 DGAT1 (0.36) ALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4097096-A2 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2022-12-07 — — EP disclosed
Send feedback